公司资料
Lifevantage 股价、新闻与催化剂
- 股票代码:
- LFVN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
6.84 USD (+2.24%)
收盘价
最后更新: 2026年8月24日
109M USD
市值
股价为何变动
The latest company update was “LifeVantage Declares Quarterly Dividend”. LFVN changed 0.60% and closed at $6.69 on Aug 21, 2026, indicating a relatively limited closing-price reaction to this company update.
公司概览
Direct-Selling Wellness Company
LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants.
Nutrigenomics Positioning
The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather than conventional nutrient replacement alone.
Product Portfolio
Key offerings include the Protandim line, the MindBody GLP-1 System and products added through LoveBiome. Sales depend on consultant recruitment, customer retention and product launches across international markets.
未来催化剂
- LifeVantage’s catalysts are product sales, distributor activity, and margin discipline in consumer wellness. The company improves when its recurring consumer base stays healthy.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。